A novel in vitro assay for human angiogenesis

Laboratory Investigation

Volumn 75, Issue 4, 1996, Pages 539-555

  Brown, Kathryn J ^a   Maynes, Susan F ^a   Bezos, Anna ^a   Maguire, Deborah J ^a   Ford, Miriam D ^b   Parish, Christopher R ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; HYDROCORTISONE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; GROWTH REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REGULATORY MECHANISM; TISSUE CULTURE; WOUND HEALING;

ANIMALS; ANTIBODIES; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HUMANS; HYDROCORTISONE; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTRALIZATION TESTS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; SURAMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

EID: 0029859044     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Arnold F and West DC (1991). Angiogenesis in wound healing. Pharmacol Ther 52:407-422.
2. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, and Thomas KA (1991). Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci USA 88:8651-8655.
3. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, and Libby P (1993). Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries: Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 92:2408-2418.
4. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, and Schlessinger J (1990). Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. Embo J 9:2685-2692.
5. Dyson M, Young SR, Hart J, Lynch JA, and Lang S (1992). Comparison of the effects of moist and dry conditions on the process of angiogenesis during dermal repair. J Invest Dermatol 99:729-733.
6. Ferrara N, Houck KA, Jakeman LB, Winer J, and Leung DW (1991). The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218.
7. Folkman J (1985). Toward an understanding of angiogenesis: Search and discovery. Perspect Biol Med 29:10-36.
8. Folkman J and Brem H (1992). Angiogenesis and Inflammation. In: Gallin JI, Goldstein IM, and Snyderman RS, editors. Inflammation: Basic principles and clinical correlates. New York: Raven Press, 809-839.
9. Folkman J and Klagsbrun M (1987). Angiogenic factors. Science 235:442-447.
10. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, and Vlodavsky I (1988). A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 130:393-400.
11. Folkman J, Langer R, Linhardt RJ, Haudenschild C, and Taylor S (1983). Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221:719-725.
12. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, and Bohlen P (1987). Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84:5277-5281.
13. Gagliardi A, Hadd H, and Collins DC (1992). Inhibition of angiogenesis by suramin. Cancer Res 52:5073-5075.
14. Gilbert E, Del GF, Champion AP, Gesnel MC, and Breathnach R (1993). Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 13:5461-5468.
15. Gospodarowicz D, Ferrara N, Schweigerer L, and Neufeld G (1987). Structural characterization and biological functions of fibroblast growth factor. Endocrinol Rev 8:95-114.
16. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, and Rosen EM (1993). Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941.
17. Ingber DE and Folkman J (1989). Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 109:317-330.
18. Isacchi A, Bergonzoni L, and Sarmientos P (1990). Complete sequence of a human receptor for acidic and basic fibroblast growth factors. Nucleic Acids Res 18:1906.
19. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, and Heldin CH (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562.
20. Jaye M, Schlessinger J, and Dionne CA (1992). Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction. Biochim Biophys Acta 1135:185-199.
21. Johnson DE, Lu J, Chen H, Werner S, and Williams LT (1991). The human fibroblast growth factor receptor genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11:4627-4634.
22. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, and Connolly DT (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312.
23. Keegan K, Johnson DE, Williams LT, and Hayman MJ (1991). Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 88:1095-1099.
24. Kendall RL and Thomas KA (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90: 10705-10709.
25. Klagsbrun M and D'Amore PA (1991). Regulators of angiogenesis. Annu Rev Physiol 53:217-239.
26. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, and Rifkin DB (1993). Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell 4:973-982.
27. Klein-Soyer C, Archipoff G, Beretz A, and Cazenave JP (1992). Opposing effects of heparin with TGF-beta or aFGF during repair of a mechanical wound of human endothelium. Influence of cAMP on cell migration. Biol Cell 75:155-162.
28. Kubota Y, Kleinman HK, Martin GR, and Lawley TJ (1988). Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107:1589-1598.
29. Ladoux A and Frelin C (1993). Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels. Biochem Biophys Res Commun, 194:799-803.
30. Langer R and Folkman J (1976). Polymers for the sustained release of proteins and other macromolecules. Nature 263: 797-800.
31. Lee K, Erturk E, Mayer R, and Cockett TK (1987). Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Cancer Res 47: 5021-5024.
32. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, and Nuseir N (1987). Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Science 329:630-632.
33. Madri JA and Williams SK (1983). Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 97:153-165.
34. Merchenthaler I, Stankovics J, and Gallyas F (1989). A highly sensitive one-step method for silver intensification of the nickel-diaminobenzidine endproduct of peroxidase reaction. J Histochem Cytochem 37:1563-1565.
35. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, and Aaronson SA (1992). Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89:246-250.
36. Minchenko A, Bauer T, Salceda S, and Caro J (1994). Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71:374-379.
37. Miyazono K, Okabe T, Urabe A, Takaku F, and Heldin CH (1987). Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262:4098-4103.
38. Montesano R, Orci L, and Vassalli P (1983). In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97:1648-1652.
39. Montesano R, Pepper MS, Vassalli JD, and Orci L (1987). Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 132:509-516.
40. Montesano R, Vassalli JD, Baird A, Guillemin R, and Orci L (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83:7297-7301.
41. Moscatelli D, Presta M, and Rifkin DB (1986). Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci USA 83:2091-2095.
42. Nicosia RF and Ottinetti A (1990). Growth of microvessels in serum-free matrix culture of rat aorta: A quantitative assay of angiogenesis in vitro. Lab Invest 63:115-122.
43. Nicosia RF, Tchao R, and Leighton J (1982). Histotypic angiogenesis in vitro: light microscopic, ultrastructural, and radioautographic studies. In Vitro 18:538-549.
44. Nurcombe V, Ford MD, Wildschut JA, and Bartlett PF (1993). Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106.
45. Paralkar VM, Vukicevic S, and Reddi AH (1991). Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: Implications for development. Dev Biol 143:303-308.
46. Park JE, Keller GA, and Ferrara N (1993). The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326.
47. Partanen J, Makela TP, Eerola E, Korhonen J, Hirvonen H, Claesson WL, and Alitalo K (1991). FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. Embo J 10:1347-1354.
48. Penhaligon M and Camplejohn RS (1985). Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice. J Natl Cancer Inst 74:869-873.
49. Pepper MS and Meda P (1992). Basic fibroblast growth factor increases junctional communication and connexin 43 expression in microvascular endothelial cells. J Cell Physiol 153:196-205.
50. Peters KG, De VC, and Williams LT (1993). Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90:8915-8919.
51. Presta M, Moscatelli D, Joseph SJ, and Rifkin DB (1986). Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol 6:4060-4066.
52. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, and Dvorak AM (1995). Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 43:381-389.
53. Reid HH, Wilks AF, and Bernard O (1990). Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc Natl Acad Sci USA 87:1596-1600.
54. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, and Presta M (1995). Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 170:39-49.
55. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, and Fauci AS (1986). Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171.
56. Safran A, Avivi A, Orr UA, Neufeld G, Lonai P, Givol D, and Yarden Y (1990). The murine flg gene encodes a receptor for fibroblast growth factor. Oncogene 5:635-643.
57. Schreiber AB, Winkler ME, and Derynck R (1986). Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 232:1250-1253.
58. Shi E, Kan M, Xu J, Wang F, Hou J, and McKeehan WL (1993). Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol Cell Biol 13:3907-3918.
59. Simorre PV, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, and Plouet J (1994). Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 35:3393-3400.
60. Stark KL, McMahon JA, and McMahon AP (1991). FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development 113:641-651.
61. Thomas KA, Rios CM, Gimenez GG, DiSalvo J, Bennett C, Rodkey J, and Fitzpatrick S (1985). Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 82:6409-6413.
62. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, and Abraham JA (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954.
63. Villaschi S and Nicosia RF (1993). Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 143:181-190.
64. Weindel K, Marme D, and Weich HA (1992). AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 183:1167-1174.
65. Werner S, Duan D-S, De Vries C, Peters KG, Johnson DE, and Williams LT (1992). Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12:82-88.
66. Zhao XM, Frist WH, Yeoh TK, and Miller GG (1994). Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection. J Clin Invest 94:992-1003.